PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables

2011-06-10
(Press-News.org) CORVALLIS, Ore. – Sulforaphane, one of the primary phytochemicals in broccoli and other cruciferous vegetables that helps them prevent cancer, has been shown for the first time to selectively target and kill cancer cells while leaving normal prostate cells healthy and unaffected.

The findings, made by scientists in the Linus Pauling Institute at Oregon State University, are another important step forward for the potential use of sulforaphone in cancer prevention and treatment. Clinical prevention trials are already under way for its use in these areas, particularly prostate and breast cancer.

It appears that sulforaphane, which is found at fairly high levels in broccoli, cauliflower and other cruciferous vegetables, is an inhibitor of histone deacetylase, or HDAC enzymes. HDAC inhibition is one of the more promising fields of cancer treatment and is being targeted from both a pharmaceutical and dietary approach, scientists say.

"It's important to demonstrate that sulforaphane is safe if we propose to use it in cancer prevention or therapies," said Emily Ho, a principal investigator in the Linus Pauling Institute, lead author on the study and associate professor in the OSU Department of Nutrition and Exercise Sciences.

"Just because a phytochemical or nutrient is found in food doesn't always mean its safe, and a lot can also depend on the form or levels consumed," Ho said. "But this does appear to be a phytochemical that can selectively kill cancer cells, and that's always what you look for in cancer therapies."

The findings were published in Molecular Nutrition and Food Research, a professional journal. Research was supported by the National Cancer Institute, National Institute of Environmental Health Sciences and the OSU Agricultural Experiment Station.

The Linus Pauling Institute has conducted some of the leading studies on sulforaphane's role as an HDAC inhibitor – one, but not all, of the mechanisms by which it may help prevent cancer. HDACs are a family of enzymes that, among other things, affect access to DNA and play a role in whether certain genes are expressed or not, such as tumor suppressor genes.

Some of the mechanisms that help prevent inappropriate cell growth – the hallmark of cancer – are circumvented in cancer cells. HDAC inhibitors can help "turn on" these silenced genes and restore normal cellular function.

Previous OSU studies done with mouse models showed that prostate tumor growth was slowed by a diet containing sulforaphane.

"It is well documented that sulforaphane can target cancer cells through multiple chemopreventive mechanisms," the researchers wrote in their study. "Here we show for the first time that sulforaphane selectively targets benign hyperplasia cells and cancerous prostate cells while leaving the normal prostate cells unaffected."

"These findings regarding the relative safety of sulforaphane to normal tissues have significant clinical relevance as the use of sulforaphane moves towards use in human clinical trials," they said.

The results also suggest that consumption of sulforaphane-rich foods should be non-toxic, safe, simple and affordable.

### END


ELSE PRESS RELEASES FROM THIS DATE:

New animal study shows promise for development of Parkinson's disease drug

2011-06-10
Amsterdam, NL, 9 June 2011 – Few treatments for Parkinson's disease (PD) restore function for extended periods. In a new study published today in the inaugural issue issue of the Journal of Parkinson's Disease, an international group of researchers report that platelet-derived growth factor-BB (PDGF-BB) restored function in rodents and shows promise as a clinical candidate drug for treatment of PD. Parkinson's disease is the second most common neurodegenerative disorder, affecting 1𔃀% of the population over the age of 65. It is characterized by loss of brain cells ...

New method for measuring Parkinson's disease prevalence reveals sharp increase in Israel

2011-06-10
Amsterdam, NL, 9 June 2011 – In a new study published today in the inaugural issue of the Journal of Parkinson's Disease, Israeli researchers report that by tracking pharmacy purchases of anti-Parkinson drugs they could estimate the number of Parkinson's disease (PD) cases in a large population. The study identified a sharp rise in PD prevalence from 170/100,000 in 2000 to 256/100,000 in 2007 in Israel, which warrants further investigation. Surprisingly, much of the world lacks accurate figures for the percentage of the population (prevalence) with PD and the rate of ...

Chemistry with sunlight

Chemistry with sunlight
2011-06-10
The idea is simple, says Kevin Moeller, PhD, and yet it has huge implications. All we are recommending is using photovoltaic cells (clean energy) to power electrochemical reactions (clean chemistry). Moeller is the first to admit this isn't new science. "But we hope to change the way people do this kind of chemistry by making a connection for them between two existing technologies," he says. To underscore the simplicity of the idea, Moeller and his co-authors used a $6 solar cell sold on the Internet and intended to power toy cars to run reactions described in an article ...

Confused.com Reveals 56% of Drivers Forget Where They Park

2011-06-10
Confused.com has revealed that 56% of UK drivers have at some point, forgotten where they have parked their car, and 3% have picked up the phone to ask their breakdown service to help them find it. More than 50 in 2,000 drivers in the UK admit to making that call according to a new survey by car insurance comparison site Confused.com. The Confused.com survey has revealed some of the gaffes of UK drivers, which have led them to phone for their breakdown service, like 25% of drivers have locked their keys in the car and 10% of drivers have had to call for their breakdown ...

Landmark study analyzes scientific productivity and impact of the top 100 PD investigators

2011-06-10
Amsterdam, NL, June 9, 2011 – IOS Press is pleased to announce the publication of a landmark study in which both traditional and innovative scientometric approaches have been employed to identify the top 100 Parkinson's disease (PD) investigators since 1985 and measure their scientific productivity as well as the impact of their contributions to the field. The article appears today in the inaugural issue of the Journal of Parkinson's Disease. This milestone analysis has been conducted by Aaron A. Sorensen, a noted expert in the fields of scientometrics and bibliometrics ...

Mayo Clinic-led research team tests alternative approach to treating diabetes

2011-06-10
JACKSONVILLE, Fla. — In a mouse study, scientists at Mayo Clinic Florida have demonstrated the feasibility of a promising new strategy for treating human type 2 diabetes, which affects more than 200 million people worldwide. In type 2 diabetes, the body stops responding efficiently to insulin, a hormone that controls blood sugar. To compensate for the insensitivity to insulin, many diabetes drugs work by boosting insulin levels; for example, by injecting more insulin or by increasing the amount of insulin secreted from the pancreas. The new study, published in the ...

Executive Healthcare Provider EliteHealth Selected by Holman Auto's Executive Team

Executive Healthcare Provider EliteHealth Selected by Holman Autos Executive Team
2011-06-10
A leading provider of executive health and corporate health programs, concierge medical service EliteHealth has been selected by the southern division of Holman Automotive Group - one of the nation's top auto dealership and leasing companies - to provide a Wellness Program for their managerial staff. The move follows a successful implementation of EliteHealth's Executive Wellness Program in 2010, which has provided concierge medical services to 15 of Holman's southern executive management group. More and more companies are recognizing that corporate success is dependent ...

Cancer protein discovery may aid radiation therapy

2011-06-10
BOSTON--Scientists at Dana-Farber Cancer Institute have uncovered a new role for a key cancer protein, a finding that could pave the way for more-effective radiation treatment of a variety of tumors. Many cancers are driven in part by elevated levels of cyclin D1, which allow the cells to escape growth controls and proliferate abnormally. In the new research, reported in the June 9 issue of Nature, researchers discovered that cyclin D1 also helps cancer cells to quickly repair DNA damage caused by radiation treatments, making the tumors resistant to the therapy. Based ...

Penn researchers show new evidence of genetic 'arms race' against malaria

2011-06-10
PHILADELPHIA — For tens of thousands of years, the genomes of malaria parasites and humans have been at war with one another. Now, University of Pennsylvania geneticists, in collaboration with an international team of scientists, have developed a new picture of one way that the human genome has fought back. The international team was led by Sarah Tishkoff, a Penn Integrates Knowledge professor with appointments in the genetics department in Penn's Perelman School of Medicine and the biology department of biology in the School of Arts and Sciences, and Wen-Ya Ko, a postdoctoral ...

Physician participation in lethal injection executions should not be banned, argue 2 ethicists

2011-06-10
(Garrison, NY) Should physicians be banned from assisting in a lethal injection execution, or lose professional certification for doing so? A recent ruling by the American Board of Anesthesiology will revoke certification of anesthesiologists who participate in capital punishment, and other medical boards may act similarly. An article in the Hastings Center Report concludes that decertification of physicians participating in lethal injections by a professional certifying organization goes too far—though individual physicians and private medical groups like the AMA are ...

LAST 30 PRESS RELEASES:

Intelligent fight: AI enhances cervical cancer detection

Breakthrough study reveals the secrets behind cordierite’s anomalous thermal expansion

Patient-reported influence of sociopolitical issues on post-Dobbs vasectomy decisions

Radon exposure and gestational diabetes

EMBARGOED UNTIL 1600 GMT, FRIDAY 10 JANUARY 2025: Northumbria space physicist honoured by Royal Astronomical Society

Medicare rules may reduce prescription steering

Red light linked to lowered risk of blood clots

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology

Climate fee on food could effectively cut greenhouse gas emissions in agriculture while ensuring a social balance

Harnessing microwave flow reaction to convert biomass into useful sugars

Unveiling the secrets of bone strength: the role of biglycan and decorin

Revealing the “true colors” of a single-atom layer of metal alloys

New data on atmosphere from Earth to the edge of space

Self-destructing vaccine offers enhanced protection against tuberculosis in monkeys

Feeding your good gut bacteria through fiber in diet may boost body against infections

Sustainable building components create a good indoor climate

High levels of disordered eating among young people linked to brain differences

Hydrogen peroxide and the mystery of fruit ripening: ‘Signal messengers’ in plants

T cells’ capability to fully prevent acute viral infections opens new avenues for vaccine development

Study suggests that magma composition drives volcanic tremor

Sea surface temperatures and deeper water temperatures reached a new record high in 2024

Connecting through culture: Understanding its relevance in intercultural lingua franca communication

Men more than three times as likely to die from a brain injury, new US study shows

Tongue cancer organoids reveal secrets of chemotherapy resistance

Applications, limitations, and prospects of different muscle atrophy models in sarcopenia and cachexia research

FIFAWC: A dataset with detailed annotation and rich semantics for group activity recognition

Transfer learning-enhanced physics-informed neural network (TLE-PINN): A breakthrough in melt pool prediction for laser melting

Holistic integrative medicine declaration

Hidden transport pathways in graphene confirmed, paving the way for next-generation device innovation

New Neurology® Open Access journal announced

[Press-News.org] Study confirms safety, cancer-targeting ability of nutrient in broccoli, other vegetables